MedPath

Primary prevention of gestational diabetes for women who are overweight and obese: a randomised controlled trial

Not Applicable
Conditions
Gestational Diabetes
Gestational weight gain
Large for gestational age infants
Self efficacy
Anxiety
Depression
Overweight/obesity
Metabolic and Endocrine - Diabetes
Reproductive Health and Childbirth - Antenatal care
Diet and Nutrition - Obesity
Registration Number
ACTRN12613000125729
Lead Sponsor
Dr Cate Nagle
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Stopped early
Sex
Female
Target Recruitment
370
Inclusion Criteria

Pregnant with gestation less than 14 weeks
Singelton pregnancy
Body Mass Index =/> 25
Able to give informed consent in English

Exclusion Criteria

Pre-exisiting diabetes
History of gestational diabetes

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Proportion of women diagnosed with Gestation Diabetes on Oral Glucose Tolerance Test. Both the criteria for the Australian Diabetes in Pregnancy Society management guidelines and the International Association of Diabetes and Pregnancy Study Groups criteria will be used and reported separately.[24 - 28 weeks gestation]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath